Headline
The latest stories from AHA Today.
The Trusted Exchange Framework and Common Agreement Recognized Coordinating Entity published updated standard operating procedures for the individual access services exchange protocol and new FAQs.
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system rates by a net 2.4% in calendar year 2027 compared to 2026.
The House Education and Workforce Subcommittee on Health, Employment, Labor and Pensions July 1 examined whether direct health care contracts between employers and providers could help address rising health care costs.
The Centers for Medicare & Medicaid Services July 1 issued its calendar year 2027 proposed rule for the home health prospective payment system. The rule proposes a 2.4% update, which includes a 3.1% market basket update, reduced by a 1.0 percentage point cut for productivity, as well as an 0.3…
The House Ways and Means Committee July 1 voted along party lines to advance a bill, H.R. 9504, the Tax-Exempt Hospitals Transparency Act, that would add reporting requirements for nonprofit hospitals’ Schedule H IRS forms. The AHA June 30 provided a statement to the committee expressing serious…
The Centers for Medicare & Medicaid Services July 1 launched the Medicare GLP-1 Bridge, a short-term demonstration program designed to provide eligible Medicare Part D beneficiaries with access to certain GLP-1 medications through Dec. 31, 2027.
Maya Sandalow, associate director of the Health Program at the Bipartisan Policy Center, shares how states are investing the funds in rural hospitals, telehealth and workforce development to improve care across rural America.
The AHA invites hospital leaders from organizations that care for children with medical complexities to join a roundtable for peer learning, collaboration and knowledge sharing.
The 2026 AHA Leadership Summit will be held July 12-14 at the Colorado Convention Center in Denver.
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices used to treat COVID-19, saying circumstances justifying the authorizations no longer exist.